Langenfeld, Germany, 16th February 2017, Vital Solutions GmbH, a specialist in natural product development, sales and marketing is pleased to announce that results of a second human study confirmed that supplementation with Careless® supports microcirculation and glucose metabolism.
Effects on microcirculation and glucose metabolism were investigated in a double-blind, randomized, placebo-controlled, parallel-design study in healthy individuals. A daily dose of 100 mg or 300 mg Careles® was compared to placebo after supplementation for 4 weeks.
100 mg Careless® improved microcirculation and confirmed results of the first human study.
300 mg Careles® reduced postprandial glucose levels accompanied by significantly lower HbA1c values compared to baseline. Furthermore, 300 mg Careles® intake significantly improved postprandial endothelial function in individuals with decreased endothelial function after high-dose glucose intake.
Dose-depending effects support the use of Careless® in different applications, said Dr. Sybille Buchwald-Werner, Managing Director at Vital Solutions. For example, Careless® at a dosage of 100 mg is interesting for products positioned for cardiovascular health or to support physical energy and endurance. Careless® at a dosage of 300 mg might be beneficial for use in concepts for healthy metabolism.
The study is published in Planta Medica, one of the leading international, peer-reviewed journal in the field of medicinal plants and natural products.
Careless® is a product of Vital Solutions. Careless® is a high quality, sustainable natural ingredient, a Mango fruit powder, which is IP protected and approved to be used in foods and food supplements.
The study is published in Planta Medica one of the leading international, peer-reviewed journals in the field of medicinal plants and natural products.